Auxilium Pharmaceuticals (AUXL)

15.13 +0.03  +0.20%  May 21, 8:00PM
Add to Watchlists Create an Alert

Auxilium Pharmaceuticals Revenue Quarterly:

66.17M for March 31, 2013
View Full Chart

Auxilium Pharmaceuticals Revenue Quarterly Chart

    Auxilium Pharmaceuticals Historical Revenue Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 66.17M
    Dec. 31, 2012 172.46M
    Sept. 30, 2012 71.04M
    June 30, 2012 78.17M
    March 31, 2012 73.61M
    Dec. 31, 2011 73.28M
    Sept. 30, 2011 66.73M
    June 30, 2011 65.94M
    March 31, 2011 58.37M
    Dec. 31, 2010 61.83M
    Sept. 30, 2010 53.63M
    June 30, 2010 50.49M
    March 31, 2010 45.48M
    Dec. 31, 2009 48.03M
    Sept. 30, 2009 42.14M
    June 30, 2009 39.19M
    March 31, 2009 34.67M
    Dec. 31, 2008 34.77M
    Sept. 30, 2008 32.58M
    June 30, 2008 30.90M
       
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro

    About Revenues

    Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.

    While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
    Learn More

    Get data for

    AUXL Revenue Quarterly Benchmarks

    Companies
    Endo Health Solutions 708.52M
    BioSpecifics Technologies Corporation 3.508M
    Pfizer 13.50B

    AUXL Revenue Quarterly Rankings

    Overall 65th percentile
    2776 of 8005
    Sector 72nd percentile
    187 of 686 in Healthcare
    Industry 73rd percentile
    18 of 68 in Drug Manufacturers - Specialty & Generic

    AUXL Revenue Quarterly Range, Past 5 Years

    Minimum 30.90M Jun 2008
    Maximum 172.46M Dec 2012
    Average 59.97M